{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:33:07Z","timestamp":1793050387709,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-017-0187-5","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T15:53:47Z","timestamp":1516636427000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":395,"title":["Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy"],"prefix":"10.1038","volume":"2","author":[{"given":"Sazid","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-9842","authenticated-orcid":false,"given":"Jinmyoung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byungji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary B.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-3560","authenticated-orcid":false,"given":"Dokyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman P.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarmo","family":"M\u00f6lder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambet","family":"Teesalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Carnazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Guglielmino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-9826","authenticated-orcid":false,"given":"Michael J.","family":"Sailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki","family":"Ruoslahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"187_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMoa055356","volume":"355","author":"GJ Moran","year":"2006","unstructured":"Moran, G. J. et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New Engl. J. Med. 355, 666\u2013674 (2006).","journal-title":"New Engl. J. Med."},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens, R. M. et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763\u20131771 (2007).","journal-title":"JAMA"},{"key":"187_CR3","first-page":"1970","volume":"173","author":"R Dantes","year":"2013","unstructured":"Dantes, R. et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern. Med. 173, 1970\u20131978 (2013).","journal-title":"JAMA Intern. Med."},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jac\/dkr437","volume":"67","author":"RC Moellering","year":"2012","unstructured":"Moellering, R. C. MRSA: the first half century. J. Antimicrob. Chemother. 67, 4\u201311 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"187_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","volume":"43","author":"M de Hoog","year":"2004","unstructured":"de Hoog, M., Mouton, J. W. & van den Anker, J. N. Vancomycin: pharmacokinetics and administration regimens in neonates. Clin. Pharmacokinet. 43, 417\u2013440 (2004).","journal-title":"Clin. Pharmacokinet."},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1345\/aph.1G436","volume":"40","author":"MP Pai","year":"2006","unstructured":"Pai, M. P., Mercier, R. C. & Koster, S. A. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann. Pharmacother. 40, 224\u2013228 (2006).","journal-title":"Ann. Pharmacother."},{"key":"187_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/jac\/16.2.235","volume":"16","author":"TC Sorrell","year":"1985","unstructured":"Sorrell, T. C. & Collignon, P. J. A prospective study of adverse reactions associated with vancomycin therapy. J. Antimicrob. Chemother. 16, 235\u2013241 (1985).","journal-title":"J. Antimicrob. Chemother."},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev.micro.112408.134309","volume":"64","author":"M Otto","year":"2010","unstructured":"Otto, M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 64, 143\u2013162 (2010).","journal-title":"Annu. Rev. Microbiol."},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/nm.2451","volume":"17","author":"I Inoshima","year":"2011","unstructured":"Inoshima, I. et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17, 1310\u20131314 (2011).","journal-title":"Nat. Med."},{"key":"187_CR10","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1021\/nn3008383","volume":"6","author":"AF Radovic-Moreno","year":"2012","unstructured":"Radovic-Moreno, A. F. et al. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano 6, 4279\u20134287 (2012).","journal-title":"ACS Nano"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0924-8579(99)00121-1","volume":"13","author":"H Pinto-Alphandary","year":"2000","unstructured":"Pinto-Alphandary, H., Andremont, A. & Couvreur, P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int. J. Antimicrob. Agents 13, 155\u2013168 (2000).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nmat4542","volume":"15","author":"CM Courtney","year":"2016","unstructured":"Courtney, C. M. et al. Photoexcited quantum dots for killing multidrug-resistant bacteria. Nat. Mater. 15, 529\u2013534 (2016).","journal-title":"Nat. Mater."},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/wnan.1282","volume":"6","author":"W Gao","year":"2014","unstructured":"Gao, W., Thamphiwatana, S., Angsantikul, P. & Zhang, L. Nanoparticle approaches against bacterial infections. Nanomed. Nanobiotechnol. 6, 532\u2013547 (2014).","journal-title":"Nanomed. Nanobiotechnol."},{"key":"187_CR14","doi-asserted-by":"publisher","first-page":"190ra181","DOI":"10.1126\/scitranslmed.3006276","volume":"5","author":"JR Morones-Ramirez","year":"2013","unstructured":"Morones-Ramirez, J. R., Winkler, J. A., Spina, C. S. & Collins, J. J. Silver enhances antibiotic activity against gram-negative bacteria. Sci. Transl. Med. 5, 190ra181 (2013).","journal-title":"Sci. Transl. Med."},{"key":"187_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/ar7000815","volume":"41","author":"PS Low","year":"2008","unstructured":"Low, P. S., Henne, W. A. & Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120\u2013129 (2008).","journal-title":"Acc. Chem. Res."},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-04-3921","volume":"65","author":"JF Kukowska-Latallo","year":"2005","unstructured":"Kukowska-Latallo, J. F. et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65, 5317\u20135324 (2005).","journal-title":"Cancer Res."},{"key":"187_CR17","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/nn700183g","volume":"2","author":"AJ Kell","year":"2008","unstructured":"Kell, A. J. et al. Vancomycin-modified nanoparticles for efficient targeting and preconcentration of gram-positive and gram-negative bacteria. ACS Nano 2, 1777\u20131788 (2008).","journal-title":"ACS Nano"},{"key":"187_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.biomaterials.2016.07.023","volume":"104","author":"L Sim\u00f3n-Gracia","year":"2016","unstructured":"Sim\u00f3n-Gracia, L. et al. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. Biomaterials 104, 247\u2013257 (2016).","journal-title":"Biomaterials"},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.1183057","volume":"328","author":"KN Sugahara","year":"2010","unstructured":"Sugahara, K. N. et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328, 1031\u20131035 (2010).","journal-title":"Science"},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature16057","volume":"527","author":"SM Lehar","year":"2015","unstructured":"Lehar, S. M. et al. Novel antibody\u2013antibiotic conjugate eliminates intracellular S. aureus. Nature 527, 323\u2013328 (2015).","journal-title":"Nature"},{"key":"187_CR21","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1002\/adma.201200653","volume":"24","author":"MJ Sailor","year":"2012","unstructured":"Sailor, M. J. & Park, J.-H. Hybrid nanoparticles for detection and treatment of cancer. Adv. Mater. 24, 3779\u20133802 (2012).","journal-title":"Adv. Mater."},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmat2398","volume":"8","author":"JH Park","year":"2009","unstructured":"Park, J.-H. et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8, 331\u2013336 (2009).","journal-title":"Nat. Mater."},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1021\/acsnano.5b01594","volume":"9","author":"J Joo","year":"2015","unstructured":"Joo, J. et al. Gated luminescence imaging of silicon nanoparticles. ACS Nano 9, 6233\u20136241 (2015).","journal-title":"ACS Nano"},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/adhm.201200335","volume":"2","author":"E Secret","year":"2013","unstructured":"Secret, E. et al. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs. Adv. Healthc. Mater. 2, 718\u2013727 (2013).","journal-title":"Adv. Healthc. Mater."},{"key":"187_CR25","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/smll.201000126","volume":"6","author":"RE Serda","year":"2010","unstructured":"Serda, R. E. et al. Cellular association and assembly of a multistage delivery system. Small 6, 1329\u20131340 (2010).","journal-title":"Small"},{"key":"187_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nnano.2008.34","volume":"3","author":"E Tasciotti","year":"2008","unstructured":"Tasciotti, E. et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nano 3, 151\u2013157 (2008).","journal-title":"Nat. Nano"},{"key":"187_CR27","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1002\/adma.201200454","volume":"24","author":"E Ruoslahti","year":"2012","unstructured":"Ruoslahti, E. Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv. Mater. 24, 3747\u20133756 (2012).","journal-title":"Adv. Mater."},{"key":"187_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nm720","volume":"8","author":"P Laakkonen","year":"2002","unstructured":"Laakkonen, P., Porkka, K., Hoffman, J. A. & Ruoslahti, E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med.. 8, 751\u2013755 (2002).","journal-title":"Nat. Med."},{"key":"187_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","volume":"16","author":"KN Sugahara","year":"2009","unstructured":"Sugahara, K. N. et al. Tissue penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell. 16, 510\u2013520 (2009).","journal-title":"Cancer Cell."},{"key":"187_CR30","doi-asserted-by":"publisher","first-page":"11980","DOI":"10.1038\/ncomms11980","volume":"7","author":"AP Mann","year":"2016","unstructured":"Mann, A. P. et al. A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. Nat. Commun. 7, 11980(2016).","journal-title":"Nat. Commun."},{"key":"187_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/iai.21.1.114-123.1978","volume":"21","author":"TF DeMaria","year":"1978","unstructured":"DeMaria, T. F. & Kapral, F. A. Pulmonary infection of mice with Staphylococcus aureus. Infect. Immun. 21, 114\u2013123 (1978).","journal-title":"Infect. Immun."},{"key":"187_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.7326\/0003-4819-144-5-200603070-00005","volume":"144","author":"MD King","year":"2006","unstructured":"King, M. D. et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144, 309\u2013317 (2006).","journal-title":"Ann. Intern. Med."},{"key":"187_CR33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.bios.2007.11.001","volume":"23","author":"S Carnazza","year":"2008","unstructured":"Carnazza, S., Foti, C., Gioffr\u00e8, G., Felici, F. & Guglielmino, S. Specific and selective probes for Pseudomonas aeruginosa from phage-displayed random peptide libraries. Biosens. Bioelectron. 23, 1137\u20131144 (2008).","journal-title":"Biosens. Bioelectron."},{"key":"187_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrmicro2508","volume":"9","author":"GE Thwaites","year":"2011","unstructured":"Thwaites, G. E. & Gant, V. Are bloodstream leukocytes Trojan horses for the metastasis of Staphylococcus aureus? Nat. Rev. Microbiol. 9, 215\u2013222 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"187_CR35","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.4049\/jimmunol.164.7.3713","volume":"164","author":"HD Gresham","year":"2000","unstructured":"Gresham, H. D. et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164, 3713\u20133722 (2000).","journal-title":"J. Immunol."},{"key":"187_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2249.2009.03950.x","volume":"157","author":"S Anwar","year":"2009","unstructured":"Anwar, S., Prince, L. R., Foster, S. J., Whyte, M. K. B. & Sabroe, I. The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes. Clin. Exp. Immunol. 157, 216\u2013224 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"187_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tim.2008.11.005","volume":"17","author":"C Garzoni","year":"2009","unstructured":"Garzoni, C. & Kelley, W. L. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 17, 59\u201365 (2009).","journal-title":"Trends Microbiol."},{"key":"187_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrmicro1384","volume":"4","author":"RA Proctor","year":"2006","unstructured":"Proctor, R. A. et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4, 295\u2013305 (2006).","journal-title":"Nat. Rev. Microbiol."},{"key":"187_CR39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nrmicro1289","volume":"3","author":"TJ Foster","year":"2005","unstructured":"Foster, T. J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3, 948\u2013958 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"187_CR40","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ajpath.2014.11.030","volume":"185","author":"SD Kobayashi","year":"2015","unstructured":"Kobayashi, S. D., Malachowa, N. & DeLeo, F. R. Pathogenesis of Staphylococcus aureus abscesses.  Am. J. Pathol. 185, 1518\u20131527 (2015).","journal-title":"Am. J. Pathol."},{"key":"187_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1189\/jlb.0407247","volume":"83","author":"JM Daley","year":"2008","unstructured":"Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S. & Albina, J. E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64\u201370 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"187_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep13500","volume":"5","author":"N Abed","year":"2015","unstructured":"Abed, N. et al. An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance. Sci. Rep. 5, 13500 (2015).","journal-title":"Sci. Rep."},{"key":"187_CR43","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1002\/adma.201600634","volume":"28","author":"J Kang","year":"2016","unstructured":"Kang, J. et al. Self-sealing porous silicon-calcium silicate core\u2013shell nanoparticles for targeted siRNA delivery to the injured brain. Adv. Mater. 28, 7962\u20137969 (2016).","journal-title":"Adv. Mater."},{"key":"187_CR44","doi-asserted-by":"publisher","first-page":"11129","DOI":"10.1021\/nn404853z","volume":"7","author":"AC Anselmo","year":"2013","unstructured":"Anselmo, A. C. et al. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano 7, 11129\u201311137 (2013).","journal-title":"ACS Nano"},{"key":"187_CR45","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/nbt.1696","volume":"28","author":"HS Choi","year":"2010","unstructured":"Choi, H. S. et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotech. 28, 1300\u20131303 (2010).","journal-title":"Nat. Biotech."},{"key":"187_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1084\/jem.95.2.209","volume":"95","author":"DE Rogers","year":"1952","unstructured":"Rogers, D. E. & Tompsett, R. The survival of staphylococci within human leukocytes.  J. Exp. Med. 95, 209\u2013230 (1952).","journal-title":"J. Exp. Med."},{"key":"187_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/emmm.201100123","volume":"3","author":"C Garzoni","year":"2011","unstructured":"Garzoni, C. & Kelley, W. L. Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus. EMBO Mol. Med. 3, 115\u2013117 (2011).","journal-title":"EMBO Mol. Med."},{"key":"187_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen, T. M. & Cullis, P. R. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug. Deliv. Rev. 65, 36\u201348 (2013).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"187_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1039\/C6NH00082G","volume":"1","author":"J Joo","year":"2016","unstructured":"Joo, J. et al. Porous silicon-graphene oxide core-shell nanoparticles for targeted delivery of siRNA to the injured brain. Nanoscale Horiz. 1, 407\u2013414 (2016).","journal-title":"Nanoscale Horiz."},{"key":"187_CR50","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1002\/adma.201400953","volume":"26","author":"H Zhang","year":"2014","unstructured":"Zhang, H. et al. Fabrication of a multifunctional nano-in-micro drug delivery platform by microfluidic templated encapsulation of porous silicon in polymer matrix. Adv. Mater. 26, 4497\u20134503 (2014).","journal-title":"Adv. Mater."},{"key":"187_CR51","doi-asserted-by":"publisher","first-page":"9867","DOI":"10.1021\/nn4035316","volume":"7","author":"J Shen","year":"2013","unstructured":"Shen, J. et al. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. ACS Nano 7, 9867\u20139880 (2013).","journal-title":"ACS Nano"},{"key":"187_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40746-3","volume-title":"Chemistry of Antibiotics and Related Drugs","author":"M Bhattacharjee","year":"2016","unstructured":"Bhattacharjee, M. Chemistry of Antibiotics and Related Drugs (Springer Science and Business Media, New York, 2016)."},{"key":"187_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/AAC.23.1.138","volume":"23","author":"BF Farber","year":"1983","unstructured":"Farber, B. F. & Moellering, R. C. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob. Agents Chemother. 23, 138\u2013141 (1983).","journal-title":"Antimicrob. Agents Chemother."},{"key":"187_CR54","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L","volume":"83","author":"LS Elting","year":"1998","unstructured":"Elting, L. S. et al. Mississippi mud in the 1990s. Cancer 83, 2597\u20132607 (1998).","journal-title":"Cancer"},{"key":"187_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0025-6196(12)65799-1","volume":"66","author":"MP Wilhelm","year":"1991","unstructured":"Wilhelm, M. P. Vancomycin. Mayo Clin. Proc. 66, 1165\u20131170 (1991).","journal-title":"Mayo Clin. Proc."},{"key":"187_CR56","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20072208","volume":"205","author":"JB Wardenburg","year":"2008","unstructured":"Wardenburg, J. B. & Schneewind, O. Vaccine protection against Staphylococcus aureus pneumonia.  J. Exp. Med. 205, 287\u2013294 (2008).","journal-title":"J. Exp. Med."},{"key":"187_CR57","doi-asserted-by":"crossref","unstructured":"Teesalu, T., Sugahara, K. N. & Ruoslahti, E. in Methods in Enzymology Vol. 503 (eds. Wittrup, K. D. & Gregory, L. V.) 35\u201356 (Academic, San Diego, 2012).","DOI":"10.1016\/B978-0-12-396962-0.00002-1"},{"key":"187_CR58","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ppsc.201300244","volume":"31","author":"Z Qin","year":"2014","unstructured":"Qin, Z., Joo, J., Gu, L. & Sailor, M. J.Size control of porous silicon nanoparticles by electrochemical perforation etching. Part. Part. Syst. Charact. 31, 252\u2013256 (2014).","journal-title":"Part. Part. Syst. Charact."},{"key":"187_CR59","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1002\/adfm.201400587","volume":"24","author":"J Joo","year":"2014","unstructured":"Joo, J., Cruz, J. F., Vijayakumar, S., Grondek, J. & Sailor, M. J. Photoluminescent porous Si\/SiO2 core\/shell nanoparticles prepared by borate oxidation. Adv. Funct. Mater. 24, 5688\u20135694 (2014).","journal-title":"Adv. Funct. Mater."},{"key":"187_CR60","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nprot.2007.478","volume":"3","author":"W Cai","year":"2008","unstructured":"Cai, W. & Chen, X. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging. Nat. Protoc. 3, 89\u201396 (2008).","journal-title":"Nat. Protoc."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-017-0187-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-017-0187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-017-0187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T02:10:03Z","timestamp":1671761403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-017-0187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1038\/s41551-017-0187-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]},"assertion":[{"value":"20 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.S. is a scientific founder of Spinnaker Biosciences, Inc., and has an equity interest in the company. Although the R01 AI132413-01 grant has been identified for conflict of interest management based on the overall scope of the project and its potential benefit to Spinnaker Biosciences, Inc., the research findings included in this particular publication may not necessarily relate to the interests of Spinnaker Biosciences, Inc. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. All the other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}